PLoS By Category | Recent PLoS Articles

Biochemistry - Oncology - Urology

Androgen Regulation of 5a-Reductase Isoenzymes in Prostate Cancer: Implications for Prostate Cancer Prevention
Published: Wednesday, December 14, 2011
Author: Jin Li et al.

by Jin Li, Zhiyong Ding, Zhengxin Wang, Jing-Fang Lu, Sankar N. Maity, Nora M. Navone, Christopher J. Logothetis, Gordon B. Mills, Jeri Kim

The enzyme 5a-reductase, which converts testosterone to dihydrotestosterone (DHT), performs key functions in the androgen receptor (AR) signaling pathway. The three isoenzymes of 5a-reductase identified to date are encoded by different genes: SRD5A1, SRD5A2, and SRD5A3. In this study, we investigated mechanisms underlying androgen regulation of 5a-reductase isoenzyme expression in human prostate cells. We found that androgen regulates the mRNA level of 5a-reductase isoenzymes in a cell type–specific manner, that such regulation occurs at the transcriptional level, and that AR is necessary for this regulation. In addition, our results suggest that AR is recruited to a negative androgen response element (nARE) on the promoter of SRD5A3 in vivo and directly binds to the nARE in vitro. The different expression levels of 5a-reductase isoenzymes may confer response or resistance to 5a-reductase inhibitors and thus may have importance in prostate cancer prevention.